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How does legalization of physician assisted suicide affect rates of suicide? 
 
Abstract 
 
Objectives. Several US states have legalized or decriminalised physician assisted suicide (PAS) whilst 
others are currently considering permitting PAS.  Although it has been suggested that legalization 
could plausibly lead to a reduction in other suicides and to a delay in those other suicides which do 
occur, to date no research has tested whether these effects can be identified in practice.  The aim of 
this paper was to fill this gap by examining the association between the legalization of physician 
assisted suicide (PAS) and state-level suicide rates in the USA between 1990 and 2013. 
 
Methods. We used regression analysis to test the change in rates of non-physician-assisted suicides 
(non-PAS) and total suicides (non-PAS plus PAS) before and after legalization of PAS. 
 
Results. Controlling for various socio-economic factors, unobservable state- and year effects, and 
state-specific linear trends, legalizing PAS was associated with a 6.3% (95% confidence interval [CI] 
= 2.70%, 9.9%) increase in suicides.  This effect was larger in the over 65s (14.5%, CI = 6.4%, 
22.7%).  Introduction of PAS was not associated with a reduction in non-PAS rates, nor with an 
increase in the mean age of non-PAS. 
 
Conclusion. Legalizing PAS has been associated with an increased rate of suicide relative to other 
states and no decrease in non-PAS.  This suggests either that PAS does not inhibit (nor acts as an 
alternative to) non-PAS, or that it acts in this way in some individuals but is associated with an 
increased inclination to suicide in other individuals. 
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Introduction 
Much attention has been paid to suicide reduction as a public health issue.1, 2  A significant stream of 
literature has focused on how socio-economic factors and policy changes may impact suicide rates at 
a population level.  It is well established that adverse economic conditions can lead to significant 
increases in suicide rates.3, 4  Individual-level attitudes (for example towards religion) are also known 
to affect suicides.5, 6, 7, 8  Other authors have found that stricter alcohol regulations can be associated 
with fewer suicides,9 whilst recent research suggests that the legalization of marijuana for medical 
purposes may have led to a reduction in male suicides.10  Reporting of celebrity suicide also seems to 
have population level effects on suicide rates.11, 12  A policy area which has received surprisingly little 
attention is the effect of changes to the legal code addressing suicide itself. 
 In recent years, several American states have moved either to legalize or to decriminalize 
some forms of assistance with suicide.  In 1998, Oregon became the first state to legalize assisted 
dying for terminally ill patients.13  Washington State passed a similar law in 2008,14 and Vermont in 
2013.15  In addition, in 2010, a court decision in Montana declared that “physician aid in dying” was 
not contrary to legal precedent or public policy.16  In 2013, there were 73 deaths under the assisted 
dying law in Oregon13 and 133 in Washington State.14  In each case, the number of non-physician-
assisted suicides (non-PAS) was about ten times higher. 
The likely effect of legalizing physician assisted suicide (PAS) on suicide rates is not easy to 
predict a priori. In the first place, it is necessary to distinguish between those deaths that conform with 
a PAS law versus non-PAS deaths (that typically are unassisted, but would also include assisted 
suicides outside the parameters of the law).  The rationale of PAS laws is to enable people who would 
otherwise have died from an underlying illness such as terminal cancer to end their lives at an earlier 
stage with the assistance of a physician.  However, in the absence of PAS, there will already be some 
people who are terminally ill who die by suicide.17  A recent estimate in the United Kingdom was that 
at least 10% of suicides involve some form of chronic or terminal illness.18  The legalization of PAS 
could provide an alternative for some people in these categories who would otherwise have died by 
non-PAS.  If so, then the direct effect of legalizing PAS would be for the total number of intentional 
self-inflicted deaths (PAS plus non-PAS) to increase but for deaths by non-PAS to decrease. 
There may also be significant indirect consequences of legalizing PAS.  Richard Posner has 
conjectured that legalizing PAS may have the effect of reducing the total number of suicides and 
postponing those that do occur.19  His reasoning was that, without access to PAS, some patients take 
their own lives earlier than they might due to concerns that, once their condition deteriorates to the 
point when they anticipate wishing to die, they may no longer be able to end their lives without 
assistance.  The knowledge that PAS is available for people who have physical incapacity enables 
such patients to delay their decision to attempt suicide.  Furthermore, some may be contemplating 
suicide because of a mistaken and overly pessimistic belief about the progress of their disease and/or 
about their ability to cope with their declining condition.  If people are enabled to delay their attempt 
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at suicide they may then come to see that they were mistaken and thus revise their suicide decision.  
As a result, “if physician-assisted suicide in cases of physical incapacity is permitted, the number of 
suicides … will be reduced … Moreover, in the fraction of cases in which suicide does occur … it 
will occur later than if physician-assisted suicide were prevented.”19  An implication of Posner’s 
conjecture about delays to suicide is that there would be an increase in the average age of suicide. 
Posner’s conjectures have come to renewed prominence in the context of debates over the 
legalization of assisted dying both sides of the Atlantic.  In the House of Lords in July 2014 it was 
argued that “many people… are dying earlier” because of the prohibition of PAS and the some “might 
have chosen to live” had PAS been legal.20  In 2014 “evidence of premature death” due to the lack of 
access to PAS was also presented before the Supreme Court of Canada.  In February 2015 the court 
concluded that “the prohibition deprives some individuals of life.”21 
Systematic empirical analysis of Posner hypothesis is limited.  Although Posner examined 
state data on suicides to illustrate his hypothesis, his data predated Oregon’s legalization of PAS.  To 
date there have been no formal tests of the impact of state-level regulation of PAS on suicide rates.  
Furthermore, no research has examined the association between PAS and age of suicides.  In the 
paper we aim to fill these gaps in knowledge and to consider the implications of this evidence. 
 
Materials and Methods 
Data on the number and age-adjusted rate of suicides (non-PAS) in each state from 1990 to 2013 were 
taken from the Center for Disease Control (CDC) Compressed Mortality Statistics22 and also from 
state-level Departments of Health.  To calculate total intentional self-inflicted deaths, we added deaths 
occurring under the auspices of the PAS regulations of Washington14 and Oregon.13  There were no 
PAS deaths recorded in Vermont in 2013.23  Montana does not record the numbers of physician-
assisted deaths and so our series may underestimate total deaths by suicide in that state.  The results 
below are robust to excluding Montana and Vermont.  Suicide rates are calculated using age-adjusted 
populations reported by the CDC. 
No data are available on whether those committing suicide were experiencing an illness 
which could make them eligible for PAS.  However, it is reasonable to assume that the proportion of 
such suicides will be higher amongst older people.  For this reason, we collected data on suicide rates 
for different age groups for the 28 states which provide such information to the CDC.  We used these 
data to calculate the number and rates of total suicide and non-PAS in those under and over the age of 
65.  Finally, we used the mid-point of age groups to estimate the mean age of suicide each year in 
those states for which data is available. 
Data on the legalization of PAS were collected from State Departments of Health.  We also 
collected data on a number of other socio-economic and demographic variables which have been 
found to affect suicide rates.  State unemployment rates were taken from the Bureau of Labor 
Statistics.  Data on per capita disposable income (adjusted for inflation) for each state were taken from 
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the Bureau of Economic Analysis.  The percentages of the population that are black and Hispanic 
were calculated from the CDC state bridged-race population estimates.  Annual data on the percentage 
of adherents to recognized religions were taken from the US Religious Census.  As these data are 
collected at irregular intervals (1990, 2000 and 2010), we used linear interpolation to estimate values 
for intervening years.  We used existing sources to collect indicators for states in which medical 
marijuana was legal in that year, for whether marijuana possession was decriminalized and whether a 
0.08 blood alcohol content law was in effect.24, 25 
We constructed graphs of rates of total deaths by suicide and deaths by non-PAS for Oregon 
and Washington and rates of suicide for Montana.  In each case, we compared these with the rates in 
all other US states. 
We then used grouped logistic regression to estimate the association between PAS and suicide 
rates.  We estimated the association for total suicide and non-PAS and also (for the 25 states with 
available data) separately for suicides by those aged under- and over-65.  The coefficient on PAS can 
be interpreted as the estimated percentage change in suicide rates associated with the legalization of 
PAS-states.  Finally we used ordinary least square (OLS) regressions to estimate the association 
between the legalization of PAS and the estimated age of non-PAS.  For the logistic regressions, we 
used Huber-White standard errors which control for heteroskedasticity.  For the OLS regressions, we 
clustered standard errors by state.  We highlighted estimates that are significantly different to zero at 
the 10%, 5% and 1% level. 
In each regression, we included an indicator (dummy) variable for each state and for each 
year.  These control for unobservable state and year fixed effects, respectively and mean that the 
coefficient on PAS legalization can be interpreted as the average percentage change in suicide rates 
before and after legalization of PAS relative to the change over the same time period in States that did 
not legalize PAS.  We estimated further specifications of our models in which we included 
independent variables measuring factors which have previously been found to be associated with 
suicides: the proportion of the population that is black, the proportion that is Hispanic, the proportion 
of the population that adheres to a recognized religion, the unemployment rate, the annual per capita 
disposable income, whether marijuana was legal for medical reasons, whether marijuana was 
decriminalized for recreational purposes and whether a 0.08 blood alcohol content law was in place.  
We also estimated a specification which includes state-specific linear trends.  These help control for 
state-specific effects which change gradually over time and which are not captured by other variables, 
though they decrease the residual variability in the dependent variable and in the covariates.  As a 
result, they may reduce the power of the tests to pick up effects as significant. 
 
Results 
Compared to non-PAS states, states legalized PAS were characterized by higher rates of suicide, 
lower rates of religious adherence and a lower proportion of the population who were black or 
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Hispanic.  On the basis of other characteristics (unemployment, per capital income and mean age of 
suicide), PAS states were very similar to the controls (see Table A1 in the Appendix). 
Table 1 reports average numbers and rates per 100,000 residents of non-PAS, PAS (where 
available) and total suicides per year in each of the four legalizing states both before and after 
legalization.  The Table also reports the equivalent figures for states which have not legalized PAS.  
Figure 1 compares presents trends of the total suicide rates in Oregon and Washington with those in 
all other US states, before and after legalization of PAS.  Figure 2 provides the same comparison for 
non-PAS suicide rates, this time including Montana. 
Table 2 reports results of grouped logistic regressions of the associations between PAS and 
total suicide rates.  Controlling for state and year fixed effects, PAS is associated with an 8.9% 
increase in suicide rates, an effect which is strongly statistically significant (95% CI = 6.6%, 11.2%).  
Once we control for a range of demographic and socio-economic factors, PAS is estimated to increase 
rates by 11.79% (95% CI = 9.3%, 14.1%).  When we include state-specific time trends, the estimated 
increase is 6.3% (95% CI = 2.7%, 9.9%). 
Table 2 also reports the estimated association between PAS and non-physician-assisted 
suicides (non-PAS).  Controlling for state and year fixed effects, PAS is estimated to be associated 
with a 1.6% increase in non-PAS rates but this is not statistically significant (95% CI = -0.8%, 3.9%).  
The estimated effect is larger and statistically significant once other covariates are included (4.4%, 
95% CI = 1.9%, 6.8%).  However, when we include state-specific linear trends, the estimated increase 
is 1.1% and not statistically significant (95% CI = -2.5%, 4.8%). 
In Table 3, we report the estimated associations between PAS and suicide for under- and 
over-65s.  We find a significant positive association with total suicides for both age groups but the 
effect for under-65s is generally smaller and not as statistically significant once we include state-
specific trends.  In no case do the estimates suggest a significantly negative association between PAS 
and non-PAS.  Indeed, for the under-65 group, the association is found to be positive though only 
significantly so when we do not include state-specific trends. 
The estimated association between the mean age of non-PAS and PAS is negative but 
generally insignificant (see Table 4).  The exception is the case in which we include covariates but not 
state time trends.  Here the estimated effect of PAS is a reduction is -0.9% and statistically significant 
(95% CI = -1.8%, 0.0%). 
Taken together, our results provide strong evidence that legalization of PAS is associated with 
increases in the overall rate of suicide.  We find no evidence that PAS is associated with reductions in 
the non-PAS rate or with increases in the mean age of death for non-PAS. 
 
Discussion 
The potential impact on suicide generally has recently become a feature of the debate over 
legalization of PAS.  Until now, however, there has been a dearth of empirical evidence to evaluate 
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such claims.  In this study we sought to address this gap by exploiting the ‘natural experiments’ which 
have occurred through various states legalizing or decriminalizing PAS at different times.  By 
examining the change in suicide rates before and after legalization relative to the change in states 
which did not legalize PAS, we are able to control for unobservable state-specific effects which might 
otherwise lead one to observe spurious correlations.  By examining changes occurring at different 
times, we can also control for time-specific unobservable factors. 
 The formal regression analysis found clear evidence that PAS has been associated with an 
increase in the overall rate of death by suicide (including both PAS and non-PAS).  These estimates 
were robust to the inclusion of state-specific time trends.  The results pertaining to non-PAS rates 
alone were equivocal.  Some estimates suggested that PAS was also associated with a significant 
increase in the rate of non-PAS.  However, when we included state-specific trends, the estimated 
association, though positive, was smaller and was not statistically significant. 
The association between PAS and total deaths by suicide is stronger for the over-65 group.  
There is no evidence that PAS is associated with significant reductions in non-PAS for either older or 
younger people.  Further, the estimates of the determinants of the mean age at suicide do not suggest 
that PAS leads, on average, to delays in non-PAS. 
It should be noted that the rise in rates of death by suicide and the absence of a fall in rates of 
non-PAS are both net effects and do not necessarily mean that legalizing PAS has no suicide-
inhibiting effects of the kind outlined by Posner and others.19, 20, 21  Rather, the results suggest that, if 
such inhibitory mechanisms exist, they are counteracted by equal or larger opposite effects.  Drawing 
on resources from social learning theory, Stack and Kposowa show how “persons socialized in 
nations with relatively high rates of suicide are more likely to be exposed to suicidal role models, 
which provide positive definitions of suicide”.5  Such mechanisms increase the level of individual 
approval of suicide and hence reinforce the high rate of suicide within the culture.  This is analogous 
to the effect of reporting11, 12, 26  that ‘normalizes’ suicide.  It may be that legalizing PAS also provides 
positive role models that help normalize suicide more generally.27 
 
Conclusion 
The evidence from suicide rates in states that have legalized PAS is not consistent with Posner’s 
conjecture that such legal changes would lead to delays in, and net reductions in, suicide.  Rather, the 
introduction of PAS seemingly induces more self-inflicted deaths than it inhibits.  Furthermore, while 
perhaps 10% of suicides involve chronic or terminal illness, the available evidence does not support 
the conjecture that legalising assisted suicide would lead to a reduction in non-physician-assisted 
suicides. This suggests either that PAS does not inhibit (nor acts as an alternative to) non-PAS, or that 
it acts in this way in some individuals but is associated with an increased inclination to suicide in 
other individuals. 
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The evidence remains equivocal on whether legalizing PAS is associated with a significant 
increase in non-PAS.  Some estimates suggested that PAS was also associated with a significant 
increase in the rate of non-PAS but when state-specific trends were included this fell below the level 
of statistical significance. 
 
 There are a number of limitations to the analysis in this study which suggest our results 
should be treated with some caution.  In the first place, only a minority of suicides take place amongst 
people who are terminally ill and might be eligible for PAS.  This may limit our ability to identify any 
direct effect of PAS on non-PAS.  That said, our finding that there was no significant decrease in non-
PAS even amongst over-65s (a group amongst which we might expect a high proportion of suicides to 
be eligible for PAS), provides some reassurance as to the robustness of our results.  Next, there are 
still relatively few states that have legalized PAS and it is hard to know how well the effects can be 
generalized.  It should also be noted that all states that have legalized or decriminalized PAS are in the 
North of the United States, indeed three of the four share a border with Canada.  There are as yet no 
analogous data for states in the South of the United States.  Further, for some PAS states, we have 
very few post-legalization observations.  It will be important to further monitor the longer term impact 
of PAS as more data points become available.  Further evidence may also resolve the question of 
whether there is a significant association between legalizing PAS and increases in non-PAS. 
Finally, our use of state and time effects and state-specific trends allow us to control for many 
unobservable differences between states.  However, it is possible that there remain other unobservable 
factors affecting observed suicide rates and which are correlated with the legalization of PAS and 
which might affect our conclusions.  For this reason, we believe it is important that the quantitative 
approach in this paper is supplemented with qualitative research looking at the circumstances and 
motivation of those who die by suicide within jurisdictions that have legalized physician assisted 
suicide, and also research looking at how attitudes to suicide vary in jurisdictions with different 
legislative frameworks in place.  Such research might help to identify mechanisms that lie behind the 
bare statistics considered in this study. 
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Figure 1: Total suicide rates per 100,000 residents in PAS and non-PAS states, 1990-
2013 
 
Notes: Vermont is excluded as PAS was legalized in 2013 and no PAS suicides were recorded in that year.  
Montana is excluded as PAS was decriminalized rather than legalized and, as such, no data are collected on 
PAS.  The vertical lines indicate the timing of the legalization of PAS in the two states. 
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Figure 2: Non-PAS rates per 100,000 residents in PAS and non-PAS states, 1990-2013 
 
 
Notes: Vermont is excluded as PAS was legalized in 2013 and no PAS suicides were recorded in that year.  The 
vertical lines indicate the timing of the legalization/decriminalization of PAS in each state. 
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Table 1: Suicides per year and rates per 100,000 in PAS and non-PAS States, 1990-2013 
  Non-PA Suicides PA Suicides Non-PAS + PAS Non-PAS States 
  N Rate N Rate N Rate N Rate 
Oregon 
Pre-PAS 495.5 15.9 0 0 495.5 15.9 29,435 11.8 
Post-PAS 590.6 15.6 47.1 1.2 637.8 16.9 32,545 11.3 
Washington 
Pre-PAS 767.7 13.3 0 0 767.7 13.3 29,984 11.3 
Post-PAS 992.8 14.0 88.0 1.2 1,080 15.3 37,301 12.2 
Montana 
Pre-PAS 177.9 19.7 0 0 177.9 19.7 30,237 11.3 
Post-PAS 233.8 22.7 - - 233.8 22.7 37,866 12.3 
Vermont 
Pre-PAS 83.9 13.5 0 0 83.87 13.5 31,180 11.4 
Post-PAS 112.0 16.8 0 0 112.0 16.8 39,069 12.5 
Notes: N is the mean number of suicides per year.  Rate is calculated per 100,000 age-adjusted 
population.  In Montana, PAS was decriminalised in 2010 but no data are collected on the number of 
assisted deaths.  The post-PAS periods are as follows: Oregon 1998-2013; Washington 2009-2013; 
Montana 2010-2013; Vermont 2013. 
 
 
Table 2: Estimates of the relationship between total suicide/non-PAS rates and PAS, 1990-2013 
 Total  Non-PAS 
State & year effects 0.089*** 
(0.066, 0.112) 
0.016 
(-0.008, 0.039) 
State & year effects + covariates 0.117*** 
(0.093, 0.141) 
0.044*** 
(0.019, 0.068) 
State & year effects + covariates & 
state time trends 
0.063*** 
(0.027, 0.099) 
0.011 
(-0.025, 0.048) 
   
Notes: results are from logistic regressions grouped by annual, state-level populations, N = 1224.  95% 
confidence intervals are reported in brackets using Huber-White standard errors.  Regression coefficients are 
reported which can be multiplied by 100 to yield percentage effects.  Logistic regression is used due to the 
dichotomous nature of the dependent variable (=1 if a resident committed suicide; = 0 if not).  Grouped 
regression reflects the fact that the data are grouped together at the state-year level.  Results using ordinary least 
squares (OLS) regression with suicide rates as the dependent variable give very similar results and are presented 
in the Appendix.  Covariates are measured at state level and include the unemployment rate, annual per capital 
real income, percentage of the population that are Hispanic, percentage of the population that are black, 
percentage of the population that report being adherents to a recognized religion, whether possession of 
marijuana was decriminalized, whether marijuana was legalized for medical purposes and whether a 0.08 blood 
alcohol law was in place. 
*** P < .01, ** P < 0.05, * P < 0.1 
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Table 3: Estimates of the relationship between total suicide/non-PAS rates and PAS, 1990-2013: 
aged under-65 and 65+ 
 Deaths by suicide under-65 Deaths by suicide aged 65+ 
 Total  Non-PAS  Total  Non-PAS  
State & year effects 0.049*** 
(0.023, 0.070) 
0.025* 
(-0.002, 0.052) 
0.197*** 
(0.144, 0.248) 
-0.005 
(-0.058, 0.049) 
State & year effects + 
covariates 
0.079*** 
(0.052, 0.107) 
0.054*** 
(0.026, 0.082) 
0.217*** 
(0.163, 0.271) 
0.014 
(-0.042, 0.071) 
State & year effects + 
covariates & state time trends 
0.044** 
(0.003, 0.086) 
0.016 
(-0.027, 0.058) 
0.145*** 
(0.064, 0.227) 
-0.045 
(-0.132, 0.041) 
Notes: results are from logit regressions grouped by annual, state-level populations, N = 975 for under-65 and 
675 for 65+.  95% confidence intervals are reported in brackets.  Regression coefficients are reported which can 
be multiplied by 100 to yield percentage effects using Huber-White standard errors.  Logistic regression is used 
due to the dichotomous nature of the dependent variable (=1 if a resident committed suicide; = 0 if not).  
Covariates are measured at state level and include the unemployment rate, annual per capital real income, 
percentage of the population that are Hispanic, percentage of the population that are black, percentage of the 
population that report being adherents to a recognized religion, whether possession of marijuana was 
decriminalized, whether marijuana was legalized for medical purposes and whether a 0.08 blood alcohol law 
was in place.  The difference between the coefficients for under-65 and 65+ are statistically significant at 
conventional levels for total suicides but not for non-PAS. 
*** P < .01, ** P < 0.05, * P < 0.1 
 
 
 
Table 4: Estimates of the relationship between natural log of mean age of Non-PAS and 
PAS, 1990-2013 
 Non-PAS  
State & year effects -0.004 
(-0.012, 0.005) 
State & year effects + covariates -0.009** 
(-0.018, -0.000) 
State & year effects + covariates & 
state time trends 
-0.010 
(-0.023, 0.004) 
Notes: results are from OLS regressions weighted by state-level populations, N = 674.  95% 
confidence intervals are reported in brackets using standard errors clustered at the state level.  
Regression coefficients are reported which can be multiplied by 100 to yield percentage effects.  
Covariates are measured at state level and include the unemployment rate, annual per capital real 
income, percentage of the population that are Hispanic, percentage of the population that are black, 
percentage of the population that report being adherents to a recognized religion, whether possession 
of marijuana was decriminalized, whether marijuana was legalized for medical purposes and whether 
a 0.08 blood alcohol law was in place. 
*** P < 0.01, ** P < 0.05, * P < 0.1 
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